CHAPTER VI CLINICAL EVIDENCE, PERFORMANCE EVALUATION AND PERFORMANCE STUDIES
- 56Performance evaluation and clinical evidence
- 57General requirements regarding performance studies
- 58Additional requirements for certain performance studies
- 59Informed consent
- 60Performance studies on incapacitated subjects
- 61Performance studies on minors
- 62Performance studies on pregnant or breastfeeding women
- 63Additional national measures
- 64Performance studies in emergency situations
- 65Damage compensation
- 66Application for performance studies
- 67Assessment by Member States
- 68Conduct of a performance study
- 69Electronic system on performance studies
- 70Performance studies regarding devices bearing the CE marking
- 71Substantial modifications to performance studies
- 72Corrective measures to be taken by Member States and information exchange between Member States on performa
- 73Information from the sponsor at the end of a performance study or in the event of a temporary halt or early
- 74Coordinated assessment procedure for performance studies
- 75Review of the coordinated assessment procedure
- 76Recording and reporting of adverse events that occur during performance studies
- 77Implementing acts
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).